Publication: Dengue virus specific T cell responses to live attenuated monovalent dengue-2 and tetravalent dengue vaccines
Issued Date
2000-12-01
Resource Type
ISSN
0125877X
Other identifier(s)
2-s2.0-0034462692
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Allergy and Immunology. Vol.18, No.4 (2000), 227-235
Suggested Citation
J. Rabablert, T. Dharakul, S. Yoksan, N. Bhamarapravati Dengue virus specific T cell responses to live attenuated monovalent dengue-2 and tetravalent dengue vaccines. Asian Pacific Journal of Allergy and Immunology. Vol.18, No.4 (2000), 227-235. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/25954
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Dengue virus specific T cell responses to live attenuated monovalent dengue-2 and tetravalent dengue vaccines
Author(s)
Other Contributor(s)
Abstract
The proliferative T cell responses to dengue vaccines were studied using the parental strains of dengue vaccines as antigens in 26 dengue immune individuals who resided in Bangkok which is the endemic area of dengue infection. The magnitude of the T cell responses in subjects with flavivirus cross-reactive neutralizing antibody was much higher and the cross-reactivity was broader than in those with dengue serotype-specific neutralizing antibodies, Japanese encephalitis (JE) specific antibodies or dengue cross-reactive antibodies. The T cell response in those with neutralizing antibody against a single serotype or in those who had dengue cross-reactive neutralizing antibody was relatively low, independent of the level or degree of cross-reactivity of the antibody. Evaluation of the proliferative T cell responses in 8 recipients of the monovalent dengue-2 (16681-PDK53) or the tetravalent dengue vaccines demonstrated that both vaccines induced high levels of neutralizing antibody as well as high levels of T cell responses to all serotypes of dengue virus. These results indicate that the evaluated dengue vaccines efficiently induced humoral and cell mediated immunity comparable to natural infection with dengue virus.